RT Journal Article
SR Electronic
T1 Does Pecs II Block Reduce the Incidence of Post Mastectomy Pain Syndrome (PMPS)? A Cross Sectional Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19006924
DO 10.1101/19006924
A1 Vimal Varma
A1 Chih N. Yeoh
A1 Choon Y. Lee
A1 Azrin M. Azidin
YR 2019
UL http://medrxiv.org/content/early/2019/09/16/19006924.abstract
AB Background and Objectives Post mastectomy pain syndrome (PMPS) is a chronic pain condition that develops after breast cancer surgery. The objective of this study was to determine if Pecs II block administered prior to general anesthesia (GA) reduced the incidence of PMPS after mastectomy and axillary clearance (MAC) when compared with conventional analgesic therapy.Methods This cross sectional study compared incidence and severity of PMPS in 288 women who underwent unilateral MAC. Questionnaire survey was done via personal and telephone interview with 145 patients who received conventional analgesic therapy versus 143 patients who received Pecs II block. Outcomes assessed included incidence, severity and chronic pain symptom and sign score of PMPS.Results We found a significantly lower incidence of PMPS in patients who received Pecs II block compared with conventional analgesic therapy [49.7% vs. 63.4%, OR 0.57 (0.36-0.91), P = 0.018], which was a 22% relative risk reduction (RR 0.78). Severity of PMPS in Pecs II group was also significantly reduced as shown by lower static and dynamic pain scores at operative site (P < 0.001). Furthermore, Pecs II group reported significantly lower Chronic Pain Symptom and Sign Score (P = 0.002) compared to conventional group.Conclusions Pecs II block prior to MAC significantly reduced the incidence of PMPS, severity of chronic pain at operative site and number of chronic pain symptoms and signs related to PMPS.This study is registered under National Medical Research Register. NMRR ID: 17-2627-38056Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNMRR ID: 17-2627-38056Funding StatementnoneAuthor DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.YesI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Yesavailable at dropbox https://www.dropbox.com/sh/atd3k409gjs79bn/AABBUulP19r7wEREIihHSRr2a?dl=0